Prognostic significance of epidermal growth factor-like domain 7 in pancreatic cancer

Hepatobiliary and Pancreatic Diseases International

Volumn 13, Issue 5, 2014, Pages 523-528

  Zhou, Li ^a   Li, Jian ^a   Zhao, Yu Pei ^a   Guo, Jun Chao ^a   Cui, Quan Cai ^a   Zhou, Wei Xun ^a   Zhang, Tai Ping ^a   Wu, Wen Ming ^a   You, Lei ^a   Shu, Hong ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

epidermal growth factor like domain 7; immunohistochemistry; pancreatic cancer; prognosis; tissue microarray; Western blotting

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR LIKE DOMAIN 7; UNCLASSIFIED DRUG; EGFL7 PROTEIN, HUMAN; ENDOTHELIAL CELL GROWTH FACTOR; TUMOR PROTEIN;

AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS CANCER; PANCREATIC CANCER CELL LINE; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR VOLUME; WESTERN BLOTTING; CHEMISTRY; METABOLISM; MIDDLE AGED; PANCREAS; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TUMOR CELL LINE;

AGED; BLOTTING, WESTERN; CELL LINE, TUMOR; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PANCREAS; PANCREATIC NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 84928684241     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(14)60272-1     Document Type: Article

References (35)

1. A Jemal, R Siegel, J Xu, E Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
2. M Hidalgo Pancreatic cancer N Engl J Med 362 2010 1605 1617
3. ER Witkowski, JK Smith, JF Tseng Outcomes following resection of pancreatic cancer J Surg Oncol 107 2013 97 103
4. M La Torre, M Cavallini, G Ramacciato, G Cosenza, S Rossi Del Monte, G Nigri et al. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis J Surg Oncol 104 2011 629 633
5. SM Robinson, A Rahman, B Haugk, JJ French, DM Manas, BC Jaques et al. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma Eur J Surg Oncol 38 2012 333 339
6. N Golse, R Lebeau, C Lombard-Bohas, V Hervieu, T Ponchon, M Adham Lymph node involvement beyond peripancreatic region in pancreatic head cancers: when results belie expectations Pancreas 42 2013 239 248
7. D Chatterjee, MH Katz, A Rashid, H Wang, AC Iuga, GR Varadhachary et al. Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma Am J Surg Pathol 36 2012 409 417
8. Y Zhang, AE Frampton, P Cohen, C Kyriakides, JJ Bong, NA Habib et al. Tumor infiltration in the medial resection margin predicts survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma J Gastrointest Surg 16 2012 1875 1882
9. D Ansari, A Rosendahl, J Elebro, R Andersson Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer Br J Surg 98 2011 1041 1055
10. JM Winter, CJ Yeo, JR Brody Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer J Surg Oncol 107 2013 15 22
11. F Soncin, V Mattot, F Lionneton, N Spruyt, F Lepretre, A Begue et al. VE-statin, an endothelial repressor of smooth muscle cell migration EMBO J 22 2003 5700 5711
12. LH Parker, M Schmidt, SW Jin, AM Gray, D Beis, T Pham et al. The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation Nature 428 2004 754 758
13. L Campagnolo, A Leahy, S Chitnis, S Koschnick, MJ Fitch, JT Fallon et al. EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury Am J Pathol 167 2005 275 284
14. D Xu, RE Perez, II Ekekezie, A Navarro, WE Truog Epidermal growth factor-like domain 7 protects endothelial cells from hyperoxia-induced cell death Am J Physiol Lung Cell Mol Physiol 294 2008 L17 L23
15. E Lelièvre, A Hinek, F Lupu, C Buquet, F Soncin, V Mattot VE-statin/egfl7 regulates vascular elastogenesis by interacting with lysyl oxidases EMBO J 27 2008 1658 1670
16. F Wu, LY Yang, YF Li, DP Ou, DP Chen, C Fan Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma Hepatology 50 2009 1839 1850
17. S Delfortrie, S Pinte, V Mattot, C Samson, G Villain, B Caetano et al. Egfl7 promotes tumor escape from immunity by repressing endothelial cell activation Cancer Res 71 2011 7176 7186
18. C Fan, LY Yang, F Wu, YM Tao, LS Liu, JF Zhang et al. The expression of Egfl7 in human normal tissues and epithelial tumors Int J Biol Markers 28 2013 71 83
19. R Díaz, J Silva, JM García, Y Lorenzo, V García, C Peña et al. Deregulated expression of miR-106a predicts survival in human colon cancer patients Genes Chromosomes Cancer 47 2008 794 802
20. CH Huang, XJ Li, YZ Zhou, Y Luo, C Li, XR Yuan Expression and clinical significance of EGFL7 in malignant glioma J Cancer Res Clin Oncol 136 2010 1737 1743
21. JJ Li, XM Yang, SH Wang, QL Tang Prognostic role of epidermal growth factor-like domain 7 protein expression in laryngeal squamous cell carcinoma J Laryngol Otol 125 2011 1152 1157
22. G Philippin-Lauridant, MC Baranzelli, C Samson, C Fournier, S Pinte, V Mattot et al. Expression of Egfl7 correlates with low-grade invasive lesions in human breast cancer Int J Oncol 42 2013 1367 1375
23. WY Chen, WJ Liu, YP Zhao, L Zhou, TP Zhang, G Chen et al. Induction, modulation and potential targets of miR-210 in pancreatic cancer cells Hepatobiliary Pancreat Dis Int 11 2012 319 324
24. WJ Liu, YP Zhao, TP Zhang, L Zhou, QC Cui, WX Zhou et al. MLH1 as a direct target of MiR-155 and a potential predictor of favorable prognosis in pancreatic cancer J Gastrointest Surg 17 2013 1399 1405
25. AM Hui, X Li, YZ Shi, T Takayama, G Torzilli, M Makuuchi Cyclin D1 overexpression is a critical event in gallbladder carcinogenesis and independently predicts decreased survival for patients with gallbladder carcinoma Clin Cancer Res 6 2000 4272 4277
26. A Knutsen, G Adell, XF Sun Survivin expression is an independent prognostic factor in rectal cancer patients with and without preoperative radiotherapy Int J Radiat Oncol Biol Phys 60 2004 149 155
27. S Biesterfeld, A Kauhausen, C Kost, I Gockel, CC Schimanski, PR Galle Preservation of HUGL-1 expression as a favourable prognostic factor in pancreatic carcinoma Anticancer Res 32 2012 3153 3159
28. M David, C Lepage, JL Jouve, V Jooste, M Chauvenet, J Faivre et al. Management and prognosis of pancreatic cancer over a 30-year period Br J Cancer 101 2009 215 218
29. W Hartwig, T Hackert, U Hinz, A Gluth, F Bergmann, O Strobel et al. Pancreatic cancer surgery in the new millennium: better prediction of outcome Ann Surg 254 2011 311 319
30. F Gansauge, S Gansauge, B Rau, A Scheiblich, B Poch, MH Schoenberg et al. Low serum levels of soluble CD44 variant 6 are significantly associated with poor prognosis in patients with pancreatic carcinoma Cancer 80 1997 1733 1739
31. G Zhou, D Chiu, D Qin, L Niu, J Cai, L He et al. Expression of CD44v6 and integrin-β1 for the prognosis evaluation of pancreatic cancer patients after cryosurgery Diagn Pathol 8 2013 146
32. GH Zhu, C Huang, ZJ Qiu, J Liu, ZH Zhang, N Zhao et al. Expression and prognostic significance of CD151, c-Met, and integrin alpha3/alpha6 in pancreatic ductal adenocarcinoma Dig Dis Sci 56 2011 1090 1098
33. JK Park, MA Kim, JK Ryu, YB Yoon, SW Kim, HS Han et al. Postoperative prognostic predictors of pancreatic ductal adenocarcinoma: clinical analysis and immunoprofile on tissue microarrays Ann Surg Oncol 19 2012 2664 2672
34. D Fong, M Steurer, P Obrist, V Barbieri, R Margreiter, A Amberger et al. Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance J Clin Pathol 61 2008 31 35
35. H Akita, H Nagano, Y Takeda, H Eguchi, H Wada, S Kobayashi et al. Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity Oncogene 30 2011 3468 3476